FDA Anti-Counterfeiting Focus Should Be Wholesaler Licensing, PDA Says

FDA and states should tighten drug wholesaler licensing requirements in a way that does not "unduly restrict the interstate business of wholesaling" by licensed companies, the Pharmaceutical Distributors Association says